2021
DOI: 10.1007/s12015-021-10192-0
|View full text |Cite
|
Sign up to set email alerts
|

Intravenously Infused Stem Cells for Cancer Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 166 publications
0
3
0
Order By: Relevance
“…On the base of a great deal of reference literatures, it has been found that when MSCs are injected intravenously into the recipient body, most of them are trapped in the pulmonary capillaries [57][58][59][60][61]. In contrast, the majority of Muse cells were able to escape from the coating of lung capillaries because of Muse cells were able to selectively cluster at the site of injury by keenly sensing S1P alarm signals, a key mediator of inflammation, rather than being trapped in lung capillaries and homing in damaged tissue during intravenous injection [49].…”
Section: Majority Of Muse Cells Escape From Lung Capillary Entrapment...mentioning
confidence: 99%
See 1 more Smart Citation
“…On the base of a great deal of reference literatures, it has been found that when MSCs are injected intravenously into the recipient body, most of them are trapped in the pulmonary capillaries [57][58][59][60][61]. In contrast, the majority of Muse cells were able to escape from the coating of lung capillaries because of Muse cells were able to selectively cluster at the site of injury by keenly sensing S1P alarm signals, a key mediator of inflammation, rather than being trapped in lung capillaries and homing in damaged tissue during intravenous injection [49].…”
Section: Majority Of Muse Cells Escape From Lung Capillary Entrapment...mentioning
confidence: 99%
“…Consistently, the ability to spontaneously differentiate into cells compatible with homing tissues in vivo after integration, even crossing oligonucleotide boundaries from mesoderm to endoderm or between ectoderm cells, is not recognized by other types of stem cells, including ESC/iPSCs and somatic stem cells such as neural and hematopoietic stem cells [59]. In addition to intravenous injection, Muse cells can also be injected locally to the site of injury.…”
Section: Majority Of Muse Cells Escape From Lung Capillary Entrapment...mentioning
confidence: 99%
“…In contrast, the majority of Muse cells were able to escape from the coating of lung capillaries because of Muse cells were able to selectively cluster at the site of injury by keenly sensing S1P alarm signals, a key mediator of inflammation, rather than being trapped in lung capillaries and homing in damaged tissue during intravenous injection (Yamada et al, 2018). Consistently, the ability to spontaneously differentiate into cells compatible with homing tissues in vivo after integration, even crossing oligonucleotide boundaries from mesoderm to endoderm or between ectoderm cells, is not recognized by other types of stem cells, including ESC/iPSCs and somatic stem cells such as neural and hematopoietic stem cells (Mercer-Smith et al, 2021). In addition to intravenous injection, Muse cells can also be injected locally to the site of injury.…”
Section: The Escape Of Muse Cells From Pulmonary Capillaries Might Be...mentioning
confidence: 99%
“…On the base of a great deal of reference literatures, it has been found that when MSCs are injected intravenously into the recipient body, most of them are trapped in the pulmonary capillaries ( Barbash et al, 2003 ; Li et al, 2008 ; Brooks et al, 2018 ; Mercer-Smith et al, 2021 ). In contrast, the majority of Muse cells were able to escape from the coating of lung capillaries because of Muse cells were able to selectively cluster at the site of injury by keenly sensing S1P alarm signals, a key mediator of inflammation, rather than being trapped in lung capillaries and homing in damaged tissue during intravenous injection ( Yamada et al, 2018 ).…”
Section: Muse Cell Repairs the Location Of The Damagementioning
confidence: 99%
“…When considering cell surface markers, commonly used therapeutic agents include surface antigens (SAs) and immune checkpoint blockades (ICBs); alternatively, the aspects of immunotherapy engaged in pathway interactions include inhibitors for Wnt, Notch, Hedgehog, PI3K, and other metabolism or niche mechanisms [ 90 , 265 , 333 ]. While the focus of this paper is on the optimization of current NC-based systems in targeting stem cell markers and pathways, alternative CSC applications like CSCs as vehicles of delivery [ 238 , 334 , 335 ] or even infused stem therapy [ 336 ] cannot be dismissed. As such, MSCs in the context of therapeutic carriers are gaining rapid popularity as a strategy to ensure ameliorated side-effects on account of improved biocompatibility [ 332 , 337 ].…”
Section: Current Regimens For Cancer Therapymentioning
confidence: 99%